Benjamin Daverman's most recent trade in Maravai LifeSciences Holdings Inc - Ordinary Shares - Class A was a trade of 89,139 Class A Common Stock done at an average price of $2.2 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Maravai LifeSciences Holdi... | Benjamin Daverman | Director | Grant, award, or other acquisition of securities at price $ 2.16 per share. | 16 Jun 2025 | 89,139 | 138,055 | - | 2.2 | 192,540 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Benjamin Daverman | Director | Grant, award, or other acquisition of securities at price $ 10.78 per share. | 23 May 2024 | 20,645 | 48,916 | - | 10.8 | 222,553 | Class A Common Stock |
| Maravai LifeSciences Holdi... | Benjamin Daverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 24,000 | 28,271 | - | 0 | Class A Common Stock | |
| Maravai LifeSciences Holdi... | Benjamin Daverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 4,271 | 4,271 | - | 0 | Class A Common Stock |